Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

K Suto

Showing results (41-50 of 47) with videos related to

Pageof 5
Sort By:
You have reached the last page of results.This site can display upto 47 results.
ACS Medicinal Chemistry Letters|July 16, 2025
Discovery of VNRX-9945, a Potent, Broadly Active Capsid Assembly Modulator as a Clinical Candidate for the Treatment of Chronic Hepatitis B Virus InfectionBin Liu, Jiangchao Yao, Thomas Haimowitz, et al.
RSC Medicinal Chemistry|April 18, 2022
The identification of highly efficacious functionalised tetrahydrocyclopenta[<i>c</i>]pyrroles as inhibitors of HBV viral replication through modulation of HBV capsid assemblyAndrew G Cole, Steven G Kultgen, Nagraj Mani, et al.
Journal of Medicinal Chemistry|September 4, 2024
Rational Design, Synthesis, and Structure-Activity Relationship of a Novel Isoquinolinone-Based Series of HBV Capsid Assembly Modulators Leading to the Identification of Clinical Candidate AB-836Andrew G Cole, Steven G Kultgen, Nagraj Mani, et al.
Bioorganic & Medicinal Chemistry Letters|May 30, 2015
Discovery of a new chemical series of BRD4(1) inhibitors using protein-ligand docking and structure-guided designBryan C Duffy, Shuang Liu, Gregory S Martin, et al.
Nature Communications|February 23, 2021
Checkpoint inhibition through small molecule-induced internalization of programmed death-ligand 1Jang-June Park, Emily P Thi, Victor H Carpio, et al.
Bioorganic & Medicinal Chemistry Letters|June 14, 2025
Identification of a p21-activated kinase 1 (PAK1) inhibitor with 10-fold selectivity against PAK2Deidre M Johns, Jason Olejniczak, Anjali Babbar, et al.
Nature|July 23, 2025
NNMT inhibition in cancer-associated fibroblasts restores antitumour immunityJanna Heide, Agnes J Bilecz, Samarjit Patnaik, et al.
Pageof 5

Showing results (41-50 of 47) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 47 results.
ACS Medicinal Chemistry Letters|July 16, 2025
Discovery of VNRX-9945, a Potent, Broadly Active Capsid Assembly Modulator as a Clinical Candidate for the Treatment of Chronic Hepatitis B Virus InfectionBin Liu, Jiangchao Yao, Thomas Haimowitz, et al.
RSC Medicinal Chemistry|April 18, 2022
The identification of highly efficacious functionalised tetrahydrocyclopenta[<i>c</i>]pyrroles as inhibitors of HBV viral replication through modulation of HBV capsid assemblyAndrew G Cole, Steven G Kultgen, Nagraj Mani, et al.
Journal of Medicinal Chemistry|September 4, 2024
Rational Design, Synthesis, and Structure-Activity Relationship of a Novel Isoquinolinone-Based Series of HBV Capsid Assembly Modulators Leading to the Identification of Clinical Candidate AB-836Andrew G Cole, Steven G Kultgen, Nagraj Mani, et al.
Bioorganic & Medicinal Chemistry Letters|May 30, 2015
Discovery of a new chemical series of BRD4(1) inhibitors using protein-ligand docking and structure-guided designBryan C Duffy, Shuang Liu, Gregory S Martin, et al.
Nature Communications|February 23, 2021
Checkpoint inhibition through small molecule-induced internalization of programmed death-ligand 1Jang-June Park, Emily P Thi, Victor H Carpio, et al.
Bioorganic & Medicinal Chemistry Letters|June 14, 2025
Identification of a p21-activated kinase 1 (PAK1) inhibitor with 10-fold selectivity against PAK2Deidre M Johns, Jason Olejniczak, Anjali Babbar, et al.
Nature|July 23, 2025
NNMT inhibition in cancer-associated fibroblasts restores antitumour immunityJanna Heide, Agnes J Bilecz, Samarjit Patnaik, et al.
Pageof 5